NCT06065007View on ClinicalTrials.gov

Quality of Life and Disease-related Symptoms in Individuals With Systemic Mastocytosis

Active, not recruitingOBSERVATIONAL
Enrollment

400

Participants

Timeline

Start Date

March 25, 2024

Primary Completion Date

September 30, 2024

Study Completion Date

November 15, 2028

Conditions
Mastocytosis, Systemic
Interventions
OTHER

No intervention

This is a cross-sectional observational study, no intervention will be implemented or exposure studied. Data for outcomes of interest will be collected via questionnaires

Trial Locations (2)

Unknown

Karolinska Institutet, Stockholm

Uppsala University, Uppsala

All Listed Sponsors
collaborator

Karolinska Institutet

OTHER

lead

Uppsala University

OTHER

NCT06065007 - Quality of Life and Disease-related Symptoms in Individuals With Systemic Mastocytosis | Biotech Hunter | Biotech Hunter